Medicine and Dentistry
Patient
100%
Child
73%
Young Adult
34%
Age
27%
Acute Lymphoblastic Leukemia
26%
Diagnosis
26%
Adolescent
21%
Oncology
20%
Hispanic
20%
Therapeutic Procedure
19%
Hepatoblastoma
18%
Obesity
18%
Diseases
17%
Combination Therapy
16%
Pediatrics Patient
15%
Neoplasm
15%
Pediatrics
15%
Osteosarcoma
14%
Event Free Survival
14%
Malignant Neoplasm
14%
Childhood Cancer
13%
Clinical Trial
13%
Gender
12%
Solid Malignant Neoplasm
11%
Chemotherapy
11%
Ganglioneuroblastoma
11%
Assessment
11%
Cohort Analysis
10%
Survival
10%
Atezolizumab
10%
Hepatosplenomegaly
10%
microRNA
10%
Rickets
10%
Myelofibrosis
10%
Hyperglycemia
10%
Nervous System
10%
Anorexia Nervosa
10%
Hemophagocytic Syndrome
10%
Rebeccamycin
10%
Desmoid Tumor
10%
Leukemia
9%
Nausea
9%
Toxicity
9%
Oncologist
8%
NK T Cell Lymphoma
8%
Radiation
8%
Relapse
8%
Clinical Oncology
8%
Sibling
8%
Familial Adenomatous Polyposis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Toxicity
47%
Solid Malignant Neoplasm
37%
Pharmacokinetics
36%
Acute Lymphoblastic Leukemia
32%
Malignant Neoplasm
24%
Mercaptopurine
20%
Chemotherapy
20%
Nausea
18%
Obesity
17%
Maximum Tolerated Dose
17%
Childhood Cancer
16%
Phase I Trials
16%
Neoplasm
15%
Rebeccamycin
15%
Diseases
14%
Clinical Trial
13%
Event Free Survival
12%
Thrombocytopenia
12%
Acupressure
11%
Phase II Trials
10%
Bryostatin 1
10%
Hyperglycemia
10%
Atezolizumab
10%
2 [[10 (2 Hydroxyethoxy) 9 Anthryl]methylamino] 2 Methyl 1,3 Propanediol
10%
9 Aminocamptothecin
10%
Raltitrexed
10%
Death
10%
Cobimetinib
10%
Irofulven
10%
Relapse
9%
Drug
8%
NK T Cell Lymphoma
8%
Osteosarcoma
8%
Neutropenia
7%
Antagonist
6%
Acivicin
6%
Enalapril Maleate
6%
Brain Tumor
6%
Antitumor Activity
6%
Chemotherapy Induced Nausea and Vomiting
6%
Bone Marrow Suppression
5%
Rhabdomyosarcoma
5%
Leukemia
5%
Immune Checkpoint Inhibitor
5%
Prognosis
5%
Antiemetic Agent
5%
Lactone
5%
Volume of Distribution
5%
Nursing and Health Professions
Child
48%
Pediatrics
29%
Patient
23%
Body Mass
20%
Symptom
20%
Chemotherapy
20%
Nausea
19%
Combination Therapy
17%
Time
16%
Acute Lymphoblastic Leukemia
16%
Screening
16%
Parent
16%
Malignant Neoplasm
13%
Diagnosis
11%
Mercaptopurine
10%
Death
10%
Toxicity
8%
Procedures
7%
Hispanic
7%
Cancer Therapy
7%
Adolescent
6%
Analysis
6%
Gender
6%
Young Adult
6%
Osteosarcoma
5%
Drug
5%
Chemotherapy Induced Nausea and Vomiting
5%
Prophylaxis
5%
Pediatrics Patient
5%
Cohort Analysis
5%
